Disease: Acute COVID-19

ADEQUATE

Serbia Belgium
|
2021-2025
  • Adults (18-64 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Acute COVID-19
  • Syndromic diagnostic testing

ORCHESTRA WP2 prospective cohort

France Italy Spain Congo Argentina The Netherlands
|
2020-2024
  • Adults (18-64 years)
  • Hospital
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Acute COVID-19
  • Blood sample
  • Nasopharyngeal swab
  • PBMC
  • Serum
  • Stool sample
  • Whole blood
  • Plasma

MERMAIDS 2

Serbia Estonia Greece Montenegro Italy Romania Spain The Netherlands
|
2022-2022
  • Adults (18-64 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Acute COVID-19
  • Blood sample
  • Nasopharyngeal swab
  • PBMC
  • Serum
  • Stool sample
  • Whole blood

EuCARE-HOSPITALISED

Sweden Italy Poland Portugal Germany Lithuania United Kingdom Kenya Brazil Mexico
|
2022
  • Adults (18-64 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Acute COVID-19
  • Blood sample
  • Nasopharyngeal swab
  • Urine sample

Villamarin

Spain
|
2022-2022
  • Adults (18-64 years)
  • Fragile population
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Molnupiravir

Tibble

United Kingdom
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • Outpatient clinic
  • Community
  • Non-hospital health centre
  • SARS-CoV-2
  • Acute COVID-19

Mazzitelli 2

Italy
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

Mazzitelli

Italy
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Molnupiravir

Gotz

Germany
|
2022-2023
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19

Evans

United Kingdom
|
2021-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Outpatient clinic
  • Community
  • Non-hospital health centre
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Monoclonal antibodies
  • Nirmatrelvir/Ritonavir
  • Sotrovimab
  • Molnupiravir

ESOA-19

Portugal
|
2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Molnupiravir